Clinical trial
A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL
NCT00774332 is registered in ClinicalTrials.gov with Cooperative Study Group A for Hematology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL
- Lead sponsor
- Cooperative Study Group A for Hematology
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- June 30, 2006
- Completion date
- December 31, 2009
- Enrollment
- 37 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia